Ticker
NAOVCompany Name
NANOVIBRONIX INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -6.11M | -261.22% | $ 2.34M |
3/31/2025 | $ -3.28M | -123.22% | $ 2.66M |
12/31/2024 | $ -2.52M | -98.36% | $ 2.56M |
9/30/2024 | $ -2.46M | -74.72% | $ 3.29M |
6/30/2024 | $ -2.31M | -68.34% | $ 3.37M |
3/31/2024 | $ -2.98M | -104.6% | $ 2.85M |
12/31/2023 | $ -3.6M | -157.77% | $ 2.28M |
9/30/2023 | $ -4.44M | -442.43% | $ 1M |
6/30/2023 | $ -5.72M | -890.2% | $ 643K |
3/31/2023 | $ -6.49M | -778.66% | $ 834K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for NANOVIBRONIX INC is calculated as follows: CF - Operations [ $ -3.1M ] / Revenues [ $ 620K ]
(=) OCF % [ -500.81% ]
Minimum
Dec 31, 2022
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |